BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SY. Current progress toward eradicating Helicobacter pylori in East Asian countries: Differences in the 2013 revised guidelines between China, Japan, and South Korea. World J Gastroenterol 2014; 20(6): 1493-1502 [PMID: 24587624 DOI: 10.3748/wjg.v20.i6.1493] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yoon K, Kim N. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of Helicobacter pylori. Korean J Gastroenterol 2018;72:104. [DOI: 10.4166/kjg.2018.72.3.104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Byambajav TO, Bira N, Choijamts G, Davaadorj D, Gantuya B, Sarantuya T, Sarantuya G, Enkhtsetseg A, Erdenetsogt D, Battulga A, Tserentogtokh T, Matsuhisa T, Yamaoka Y, Oyuntsetseg K. Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia. Front Pharmacol 2019;10:394. [PMID: 31040783 DOI: 10.3389/fphar.2019.00394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Huh KY, Chung H, Kim YK, Lee S, Bhatia S, Takanami Y, Nakaya R, Yu KS. Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. Br J Clin Pharmacol 2021. [PMID: 34080718 DOI: 10.1111/bcp.14934] [Reference Citation Analysis]
4 Yoon H. Atrophic Gastritis and Intestinal Metaplasia. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 515-20. [DOI: 10.1007/978-981-287-706-2_52] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Moon HW, Lee SY, Hur M, Yun YM. Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study. Korean J Intern Med 2018;33:893-901. [PMID: 29061033 DOI: 10.3904/kjim.2016.353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Lee SY. There Is No Reason to Delay Helicobacter pylori Eradication after Treatment for Upper Gastrointestinal Bleeding. Gut Liver 2015;9:259-60. [PMID: 25918256 DOI: 10.5009/gnl14499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Hiroi S, Sugano K, Tanaka S, Kawakami K. Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data. BMJ Open 2017;7:e015855. [PMID: 28760790 DOI: 10.1136/bmjopen-2017-015855] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
8 Han YM, Park JM, Jeong M, Yoo JH, Kim WH, Shin SP, Ko WJ, Hahm KB. Dietary, non-microbial intervention to prevent Helicobacter pylori-associated gastric diseases. Ann Transl Med 2015;3:122. [PMID: 26207250 DOI: 10.3978/j.issn.2305-5839.2015.03.50] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
9 Jung DH, Kim JH, Chung HS, Park JC, Shin SK, Lee SK, Lee YC. Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis. PLoS One 2015;10:e0124725. [PMID: 25915048 DOI: 10.1371/journal.pone.0124725] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
10 Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY. The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations. Helicobacter. 2018;23:e12464. [PMID: 29345408 DOI: 10.1111/hel.12464] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
11 Takashima T, Enomoto H, Iwata Y, Nishikawa H, Yoh K, Hasegawa K, Nakano C, Yuri Y, Ishii N, Miyamoto Y, Takata R, Nishimura T, Ishii A, Sakai Y, Aizawa N, Ikeda N, Iijima H, Nishiguchi S. Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients. J Clin Med Res 2016;8:854-8. [PMID: 27829950 DOI: 10.14740/jocmr2725w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Choi JM, Kim SG. Diagnosis and Treatment of <i>Helicobacter Pylori</i> Infection: Korean and Overseas Guidelines. Korean J Med 2015;89:157-68. [DOI: 10.3904/kjm.2015.89.2.157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
13 Lee YC, Chiang TH, Liou JM, Chen HH, Wu MS, Graham DY. Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations. Gut Liver 2016;10:12-26. [PMID: 26696028 DOI: 10.5009/gnl15091] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
14 Nakashima H, Kawahira H, Kawachi H, Sakaki N. Artificial intelligence diagnosis of Helicobacter pylori infection using blue laser imaging-bright and linked color imaging: a single-center prospective study. Ann Gastroenterol. 2018;31:462-468. [PMID: 29991891 DOI: 10.20524/aog.2018.0269] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
15 Tanabe H, Yoshino K, Ando K, Nomura Y, Ohta K, Satoh K, Ichiishi E, Ishizuka A, Otake T, Kohgo Y, Fujiya M, Okumura T. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. Ann Clin Microbiol Antimicrob 2018;17:29. [PMID: 29950163 DOI: 10.1186/s12941-018-0281-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
16 Kim JH, Lee S, Kwon HG, Lee SP, Kim JH, Sung I, Park HS, Shim CS. Serological Changes after Equivocal Helicobacter pylori -serology Test Findings Dependent on Gastric Secreting Ability. Korean J Gastroenterol 2017;70:181. [DOI: 10.4166/kjg.2017.70.4.181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
17 Itoh T, Kawahira H, Nakashima H, Yata N. Deep learning analyzes Helicobacter pylori infection by upper gastrointestinal endoscopy images. Endosc Int Open 2018;6:E139-44. [PMID: 29399610 DOI: 10.1055/s-0043-120830] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 18.0] [Reference Citation Analysis]
18 Lee WY, Oh E, Cui M, Kim CO, Lim Y, Kim H, Park H, Yoon S, Park MS, Hong T. Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects. Transl Clin Pharmacol 2020;28:55-65. [PMID: 32274381 DOI: 10.12793/tcp.2020.28.e5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Lee SY, Moon HW, Hur M, Yun YM. Validation of western Helicobacter pylori IgG antibody assays in Korean adults. J Med Microbiol. 2015;64:513-518. [PMID: 25752852 DOI: 10.1099/jmm.0.000050] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
20 Park HW, Jeon SW. Clinical Outcomes of Patients with Non-ulcer and Non-variceal Upper Gastrointestinal Bleeding: A Prospective Multicenter Study of Risk Prediction Using a Scoring System. Dig Dis Sci 2018;63:3253-61. [PMID: 30132232 DOI: 10.1007/s10620-018-5255-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Lee JY, Park KS. Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies. Gastroenterol Res Pract 2016;2016:9086581. [PMID: 28070184 DOI: 10.1155/2016/9086581] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tanabe H, Ando K, Sato K, Ito T, Goto M, Sato T, Fujinaga A, Kawamoto T, Utsumi T, Yanagawa N, Ichiishi E, Otake T, Kohgo Y, Nomura Y, Ueno N, Sugano H, Kashima S, Moriichi K, Fujiya M, Okumura T. Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature. Dig Dis Sci 2017;62:3069-76. [DOI: 10.1007/s10620-017-4664-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
23 Miftahussurur M, Yamaoka Y. Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int 2016;2016:4819423. [PMID: 26904678 DOI: 10.1155/2016/4819423] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 8.3] [Reference Citation Analysis]
24 Biranjia-Hurdoyal SD, Seetulsingh-Goorah SP. Performances of Four Helicobacter pylori Serological Detection Kits Using Stool Antigen Test as Gold Standard. PLoS One 2016;11:e0163834. [PMID: 27736910 DOI: 10.1371/journal.pone.0163834] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
25 Hu Q, Zhang Y, Zhang X, Fu K. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management. Biomark Res. 2016;4:15. [PMID: 27468353 DOI: 10.1186/s40364-016-0068-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
26 Mihmanli M, Ilhan E, Idiz UO, Alemdar A, Demir U. Recent developments and innovations in gastric cancer. World J Gastroenterol 2016; 22(17): 4307-4320 [PMID: 27158199 DOI: 10.3748/wjg.v22.i17.4307] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
27 Moon HW, Lee SY, Hur M, Yun YM. Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study. Korean J Intern Med. 2018;33:893-901. [PMID: 29061033 DOI: 10.3904/kjim.2016.353.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Kiyotoki S, Nishikawa J, Sakaida I. Efficacy of Vonoprazan for Helicobacter pylori Eradication. Intern Med 2020;59:153-61. [PMID: 31243237 DOI: 10.2169/internalmedicine.2521-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
29 McFarland LV, Huang Y, Wang L, Malfertheiner P. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J. 2016;4:546-561. [PMID: 27536365 DOI: 10.1177/2050640615617358] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
30 Jung YS, Kim EH, Park CH. Systematic review with meta-analysis: The efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. Aliment Pharmacol Ther. 2017;46:106-114. [PMID: 28497487 DOI: 10.1111/apt.14130] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 11.8] [Reference Citation Analysis]
31 Walldorf J, Jähnert T, Berman NB, Fischer MR. Using Foreign Virtual Patients With Medical Students in Germany: Are Cultural Differences Evident and Do They Impede Learning? J Med Internet Res 2016;18:e260. [PMID: 27678418 DOI: 10.2196/jmir.6040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Jimura N, Fujii K, Higashi Y, Kanekura T. Idiopathic thrombocytopenic purpura in a patient with IgG4-related disease. Clin Exp Dermatol 2018;43:941-3. [PMID: 29888414 DOI: 10.1111/ced.13688] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Lee KD, Kayano T, Nishiura H. Dramatic shift in the epidemiology of peptic ulcer in Japan: the impact of Helicobacter pylori eradication therapy. Epidemiol Infect 2022;150. [DOI: 10.1017/s095026882100265x] [Reference Citation Analysis]
34 Kim N. Serology. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 113-8. [DOI: 10.1007/978-981-287-706-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]